SCHEMBL2097237

SCHEMBL2097237

CCC(C(=O)OC)C(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.50
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
ZDHHC7 Q9NXF8 1/20 0.40
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
MME P08473 1/20 0.37
CA14 Q9ULX7 2/20 0.37
ALDH1A1 P00352 3/20 0.36
TSHR P16473 2/20 0.36
CA12 O43570 2/20 0.36
MMP1 P03956 2/20 0.36
MMP2 P08253 2/20 0.36
MMP8 P22894 1/20 0.36
CA9 Q16790 1/20 0.36
PTPRB P23467 1/20 0.35
MIF P14174 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL221074 0.90 GAA (0.44) SMN1; SMN2CA1CA2MGAMGAA
SCHEMBL384162 0.90 SMN1; SMN2 (0.42) SMN1; SMN2CA1CA2ZDHHC7MGAM
SCHEMBL3883424 0.89 SMN1; SMN2 (0.46) SMN1; SMN2CA1CA2ZDHHC7MGAM
SCHEMBL11347511 0.89 SMN1; SMN2 (0.46) SMN1; SMN2CA1CA2ZDHHC7MGAM
SCHEMBL222338 0.87 SMN1; SMN2 (0.44) SMN1; SMN2CA1CA2ZDHHC7MGAM
SCHEMBL28471212 0.86 CA1 (0.44) SMN1; SMN2CA1CA2ZDHHC7MME
SCHEMBL2564479 0.85 SMN1; SMN2 (0.42) SMN1; SMN2CA1CA2ZDHHC7MGAM
SCHEMBL2334594 0.85 SMN1; SMN2 (0.42) SMN1; SMN2CA1CA2ZDHHC7MGAM
SCHEMBL286723 0.85 SMN1; SMN2 (0.42) SMN1; SMN2CA1CA2ZDHHC7MGAM
SCHEMBL4477961 0.84 CA1 (0.42) SMN1; SMN2CA1CA2ZDHHC7GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119390574-A 1, 4-Fullerene C60Derivatives and process for preparing the same 吉林化工学院 2025-02-07 CN claimed
CN-114605622-B Aliphatic polyester with malonic acid structure, and preparation method and application thereof 苏州瀚海新材料有限公司 2024-04-02 CN claimed
CN-117700654-A Copolyester for weather-resistant coating and preparation method and application thereof 中瀚新材料科技有限公司 2024-03-15 CN claimed
CN-117186016-A Benzotriazole compound, preparation method and application thereof 贵州大学 2023-12-08 CN claimed
CN-113929650-B Synthesis method of 2, 3-unsaturated sugar-carbon glycoside compounds 三峡大学 2023-08-01 CN claimed
US-20230223869-A1 ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION C-Motive Technologies, Inc. (US) 2023-07-13 US claimed
US-11601069-B2 Electrostatic machines that include a malonate in a dielectric fluid C-Motive Technologies, Inc. (US) 2023-03-07 US claimed
CN-114605622-A Aliphatic polyester with malonic acid structure and preparation method and application thereof 苏州瀚海新材料有限公司 2022-06-10 CN claimed
CN-113929650-A Synthesis method of 2, 3-unsaturated sugar carbon glycoside compounds 三峡大学 2022-01-14 CN claimed
US-20210391809-A1 ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION NATIONAL SCIENCE FOUNDATION 2021-12-16 US claimed
CN-104910001-A Synthetic method of 5-chloro-1-indanone XU WEI 2015-09-16 CN claimed
EP-1754747-B1 PHOTOINITIATOR COMPOSITION INCLUDING HINDERED AMINE STABILIZER BLUESTAR SILICONES FRANCE (FR) 2015-02-25 EP claimed
CN-102557851-B New method for synthesizing tapentadol hydrochloride and analogue of tapentadol hydrochloride ANHUI NEW STAR PHARMACEUTICAL DEV CO LTD 2014-03-26 CN claimed
CN-102557851-A New method for synthesizing tapentadol hydrochloride and analogue of tapentadol hydrochloride ANHUI NEW STAR PHARMACEUTICAL DEV CO LTD 2012-07-11 CN claimed
CN-101337874-B Method for preparing indanone compounds SHANGHAI RESEARCH INSTITUTE OF CHEMICAL INDUSTRY (CN) 2011-12-14 CN claimed
CN-101337874-A Method for preparing indanone compounds SHANGHAI CHEMICAL ACADEMY (CN) 2009-01-07 CN claimed
US-6415614-B1 CONTROLLING VAPOR PRESSURE OF MIXTURE VISTEON GLOBAL TECHNOLOGIES, INC. 2002-07-09 US claimed
US-12435061-B2 Compounds and compositions for use in treating skin disorders KAMARI PHARMA LTD. (IL) 2025-10-07 US disclosed
US-4316025-A STABVILIZERS FOR POLYMERS CHIMOSA CHIMICA ORGANICA S.P.A. (IT) 1982-02-16 US disclosed
US-4076601-A FROM DIMETHYL MALONATE MONSANTO COMPANY (US) 1978-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12435061-B2 Compounds and compositions for use in treating skin disorders RDX, HAX1, F12 SMN1; SMN2 3452/4885CA1 1553/4885CA2 341/4885
US-20210391809-A1 ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION EZH2, LAGE3, CHD4 SMN1; SMN2 3071/4885CA1 118/4885CA2 747/4885
US-11601069-B2 Electrostatic machines that include a malonate in a dielectric fluid MAL2, SELE, LAGE3 SMN1; SMN2 3344/4885CA1 174/4885CA2 797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.